Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

CDNA CareDx Inc

Price (delayed)

$17.26

Market cap

$961.05M

P/E Ratio

15.27

Dividend/share

N/A

EPS

$1.13

Enterprise value

$895.82M

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
CareDx's EPS has soared by 133% YoY and by 13% from the previous quarter
CareDx's net income has soared by 132% YoY and by 12% from the previous quarter
The debt has declined by 10% year-on-year but it has grown by 8% since the previous quarter
The company's quick ratio fell by 10% YoY and by 2.7% QoQ

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
55.68M
Market cap
$961.05M
Enterprise value
$895.82M
Valuations
Price to earnings (P/E)
15.27
Price to book (P/B)
2.52
Price to sales (P/S)
2.75
EV/EBIT
18.8
EV/EBITDA
13.35
EV/Sales
2.59
Earnings
Revenue
$346.42M
Gross profit
$234.31M
Operating income
$46.73M
Net income
$58.86M
EBIT
$47.64M
EBITDA
$67.12M
Free cash flow
$20.15M
Per share
EPS
$1.13
EPS diluted
$1.06
Free cash flow per share
$0.36
Book value per share
$6.84
Revenue per share
$6.27
TBVPS
$7.46
Balance sheet
Total assets
$489.64M
Total liabilities
$110.29M
Debt
$24.07M
Equity
$379.35M
Working capital
$264.96M
Liquidity
Debt to equity
0.06
Current ratio
4.11
Quick ratio
3.55
Net debt/EBITDA
-0.97
Margins
EBITDA margin
19.4%
Gross margin
67.6%
Net margin
17%
Operating margin
13.5%
Efficiency
Return on assets
12.2%
Return on equity
18.2%
Return on invested capital
19.7%
Return on capital employed
11.8%
Return on sales
13.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
-2.71%
1 week
7.74%
1 month
1.89%
1 year
14.08%
YTD
-19.38%
QTD
-2.76%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$346.42M
Gross profit
$234.31M
Operating income
$46.73M
Net income
$58.86M
Gross margin
67.6%
Net margin
17%
CDNA financials
CareDx's net income has soared by 132% YoY and by 12% from the previous quarter
The net margin has surged by 125% year-on-year and by 8% since the previous quarter
The operating income has surged by 123% year-on-year and by 15% since the previous quarter
CareDx's operating margin has soared by 118% YoY and by 11% from the previous quarter

Price vs fundamentals

How does CDNA's price correlate with its fundamentals
Price vs fundamentals
Earnings waterfall
Price vs fair value

Growth

What is CareDx's growth rate over time
CDNA growth chart

Valuation

What is CareDx stock price valuation
P/E
15.27
P/B
2.52
P/S
2.75
EV/EBIT
18.8
EV/EBITDA
13.35
EV/Sales
2.59
Valuation vs average
Price to earnings (P/E)
CareDx's EPS has soared by 133% YoY and by 13% from the previous quarter
Price to book (P/B)
The equity has increased by 48% YoY
The stock's price to book (P/B) is 41% less than its 5-year quarterly average of 4.4 and 30% less than its last 4 quarters average of 3.7
Price to sales (P/S)
The price to sales (P/S) is 57% less than the 5-year quarterly average of 6.6 and 21% less than the last 4 quarters average of 3.6
The revenue has increased by 26% YoY and by 3.8% QoQ

Efficiency

How efficient is CareDx business performance
CDNA's return on assets has surged by 132% year-on-year and by 10% since the previous quarter
The ROE has soared by 132% YoY
The ROIC has soared by 127% YoY and by 13% QoQ
CareDx's ROS has soared by 119% YoY and by 12% from the previous quarter

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
Assets vs liabilities
CareDx's total liabilities has decreased by 44% YoY and by 2.1% from the previous quarter
The company's quick ratio fell by 10% YoY and by 2.7% QoQ
Debt vs equity
The debt is 94% smaller than the equity
The equity has increased by 48% YoY
CareDx's debt to equity has decreased by 40% YoY
Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.